LoginRegister
    Zydus Cadila gets USFDA nod for Aripiprazole tabletsZydus Cadila gets USFDA nod for Aripiprazole tablets
    Lupin gets European Commission nod for NaMusclaLupin gets European Commission nod for NaMuscla
    Sanofi to pay Regeneron $462 million in revised immuno-oncology dealSanofi to pay Regeneron $462 million in revised immuno-oncology deal
    New York City launches $100 million universal health insurance programNew York City launches $100 million universal health insurance program
    Relief to Wockhardt: HC sets aside ban on Ace Proxyvon- Aceclofenac, Paracetamol, Rabeprazole ComboRelief to Wockhardt: HC sets aside ban on Ace Proxyvon- Aceclofenac, Paracetamol, Rabeprazole Combo
    Lupin gets USFDA nod for generic schizophrenia drugLupin gets USFDA nod for generic schizophrenia drug
    Building speciality portfolio of around 150 products in next 3 fiscal yrs: AurobindoBuilding speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo
    Eli Lilly to acquire Loxo Oncology for $8 billionEli Lilly to acquire Loxo Oncology for $8 billion
    Takeda unlikely to sell OTC drug business - CEOTakeda unlikely to sell OTC drug business - CEO
    Medical Insurance to refund MRI, pre-operation expenses under mediclaim : Consumer PanelMedical Insurance to refund MRI, pre-operation expenses under mediclaim : Consumer Panel
    Fighting Parkinsons: Medica Hospital to launch new treatment in eastern IndiaFighting Parkinsons: Medica Hospital to launch new treatment in eastern India
    Lupin receives FDA approval for Lurasidone Hydrochloride TabletsLupin receives FDA approval for Lurasidone Hydrochloride Tablets
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X